More funding for VIB to realise ambitious plans for future
Flanders is increasing its investment in the Ghent-based research centre by 34% based on its successes and plans for the future
From lab to market
“VIB is internationally recognised for its research excellence and proactive approach to translating research results into economic and social added value,” said Muyters in a statement. “VIB contributes substantially to the success of the Flemish biotechnology sector.”
VIB’s future plans include new initiatives to turn research into products, jobs and start-ups in Flanders more quickly and efficiently. “This grant increase allows us to further increase our social impact,” said VIB co-managing director Jo Bury.
The research centre, which produces research applicable to the pharmaceutical and agricultural sectors, as well as to various industrial applications, pointed out that more than 700 jobs and €930 million in investments are the results of its start-ups and the establishment of V-BioVentures. The V-BioVentures investment fund has raised nearly €76 million, about 40% of it from the European Investment Fund, based on VIB’s reputation.
VIB also announced the start of a new programme called Grand Challenges. “We will combine the strengths of various partners from Flanders and worldwide, within and outside the life sciences sector, to address the greatest challenges the future holds,” said Johan Cardoen, the institute’s other co-manager.
Photo courtesy VIB
Flemish Institute for Biotechnology (VIB)
institute was founded